Samsung Bioepis' bone loss biosimilar gains domestic approval ()

logo
TheKoreaTimes Breaking News
· 12 hours ago
Samsung Bioepis' bone loss biosimilar gains domestic approval

Samsung Bioepis said Sunday its biosimilar treatment for osteoporosis and bone loss has won approval from Korea's Ministry of Food and Drug Safety.

banner

Continue reading